Eran Daniel Metzger, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Delirium | 24 | 2024 | 1667 | 1.680 |
Why?
|
Long-Term Care | 2 | 2017 | 633 | 0.860 |
Why?
|
Group Processes | 1 | 2022 | 226 | 0.740 |
Why?
|
Dementia | 8 | 2024 | 2686 | 0.740 |
Why?
|
Advance Directives | 1 | 2022 | 248 | 0.690 |
Why?
|
Bulimia | 8 | 2008 | 400 | 0.610 |
Why?
|
Personal Autonomy | 2 | 2017 | 304 | 0.530 |
Why?
|
Nursing Homes | 5 | 2017 | 1081 | 0.470 |
Why?
|
Leadership | 1 | 2022 | 1385 | 0.420 |
Why?
|
Terminal Care | 1 | 2022 | 1760 | 0.340 |
Why?
|
Psychometrics | 7 | 2024 | 3064 | 0.320 |
Why?
|
Antipsychotic Agents | 5 | 2023 | 3067 | 0.310 |
Why?
|
Sexual Behavior | 1 | 2017 | 2179 | 0.290 |
Why?
|
Haloperidol | 4 | 2023 | 389 | 0.230 |
Why?
|
Ethics Committees, Clinical | 1 | 2003 | 56 | 0.210 |
Why?
|
Proxy | 1 | 2003 | 151 | 0.190 |
Why?
|
Loneliness | 1 | 2023 | 203 | 0.180 |
Why?
|
Postoperative Complications | 7 | 2021 | 15647 | 0.180 |
Why?
|
Homes for the Aged | 1 | 2003 | 272 | 0.180 |
Why?
|
Amylases | 1 | 1999 | 170 | 0.160 |
Why?
|
Dexmedetomidine | 1 | 2023 | 319 | 0.160 |
Why?
|
Psychopharmacology | 1 | 2020 | 148 | 0.160 |
Why?
|
Alzheimer Disease | 4 | 2024 | 8592 | 0.160 |
Why?
|
Truth Disclosure | 1 | 2003 | 434 | 0.160 |
Why?
|
Decision Making | 2 | 2022 | 3929 | 0.160 |
Why?
|
Severity of Illness Index | 5 | 2024 | 15835 | 0.150 |
Why?
|
Ischemic Attack, Transient | 1 | 2023 | 879 | 0.150 |
Why?
|
Salivary Glands | 1 | 1999 | 229 | 0.150 |
Why?
|
Frail Elderly | 1 | 2003 | 763 | 0.140 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 2 | 2022 | 1988 | 0.140 |
Why?
|
Video Recording | 1 | 2022 | 966 | 0.140 |
Why?
|
Aged | 31 | 2024 | 169179 | 0.140 |
Why?
|
Neuropsychological Tests | 3 | 2016 | 7045 | 0.140 |
Why?
|
Benzodiazepines | 3 | 2023 | 1132 | 0.120 |
Why?
|
Geriatric Assessment | 2 | 2020 | 1409 | 0.120 |
Why?
|
C-Reactive Protein | 2 | 2017 | 3824 | 0.120 |
Why?
|
Aging | 5 | 2021 | 8704 | 0.110 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2021 | 6019 | 0.110 |
Why?
|
Humans | 50 | 2024 | 761326 | 0.110 |
Why?
|
Telephone | 1 | 2016 | 627 | 0.100 |
Why?
|
Leptin | 1 | 2000 | 1595 | 0.100 |
Why?
|
Antidepressive Agents | 3 | 2023 | 2897 | 0.100 |
Why?
|
Torsades de Pointes | 1 | 1993 | 78 | 0.100 |
Why?
|
Academic Medical Centers | 2 | 2020 | 2760 | 0.100 |
Why?
|
Reproducibility of Results | 8 | 2024 | 20092 | 0.100 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2021 | 1472 | 0.100 |
Why?
|
Pneumonia | 1 | 2022 | 2140 | 0.090 |
Why?
|
Anorexia Nervosa | 2 | 1997 | 1361 | 0.090 |
Why?
|
Aged, 80 and over | 13 | 2024 | 58946 | 0.090 |
Why?
|
Psychomotor Agitation | 1 | 1993 | 305 | 0.090 |
Why?
|
Adaptation, Psychological | 2 | 2019 | 2630 | 0.090 |
Why?
|
Serotonin | 4 | 2000 | 1041 | 0.090 |
Why?
|
Risperidone | 2 | 2023 | 381 | 0.090 |
Why?
|
Hospitalization | 5 | 2022 | 10715 | 0.080 |
Why?
|
Accidental Falls | 1 | 2017 | 1068 | 0.080 |
Why?
|
Cognition Disorders | 2 | 2016 | 3979 | 0.080 |
Why?
|
Physician-Patient Relations | 1 | 2022 | 3249 | 0.080 |
Why?
|
Female | 31 | 2024 | 392485 | 0.080 |
Why?
|
Long QT Syndrome | 1 | 1993 | 467 | 0.080 |
Why?
|
Delphi Technique | 1 | 2012 | 846 | 0.080 |
Why?
|
Caregivers | 1 | 2019 | 2235 | 0.070 |
Why?
|
Prospective Studies | 10 | 2023 | 54405 | 0.070 |
Why?
|
Convalescence | 1 | 2007 | 105 | 0.070 |
Why?
|
Family | 1 | 2017 | 3197 | 0.070 |
Why?
|
Tryptophan | 3 | 2000 | 482 | 0.070 |
Why?
|
Bulimia Nervosa | 1 | 2007 | 206 | 0.060 |
Why?
|
Hospitals | 3 | 2023 | 3878 | 0.060 |
Why?
|
Drug Utilization | 1 | 2010 | 1188 | 0.060 |
Why?
|
Algorithms | 3 | 2020 | 14025 | 0.060 |
Why?
|
Health Care Surveys | 1 | 2010 | 2426 | 0.050 |
Why?
|
Ethics, Institutional | 1 | 2003 | 38 | 0.050 |
Why?
|
Fenfluramine | 2 | 2000 | 58 | 0.050 |
Why?
|
Ethics, Clinical | 1 | 2003 | 101 | 0.050 |
Why?
|
Male | 18 | 2024 | 360621 | 0.050 |
Why?
|
Friends | 1 | 2003 | 149 | 0.050 |
Why?
|
Self Concept | 1 | 2008 | 1043 | 0.050 |
Why?
|
Depression | 1 | 2021 | 8122 | 0.050 |
Why?
|
Cohort Studies | 5 | 2023 | 41440 | 0.050 |
Why?
|
Belgium | 1 | 2021 | 117 | 0.050 |
Why?
|
Amino Acids | 2 | 2000 | 1718 | 0.050 |
Why?
|
Mass Screening | 4 | 2022 | 5428 | 0.050 |
Why?
|
Longitudinal Studies | 4 | 2023 | 14597 | 0.050 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2001 | 109 | 0.050 |
Why?
|
Brain Diseases | 1 | 2010 | 1545 | 0.050 |
Why?
|
Prolactin | 2 | 2000 | 625 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2022 | 14665 | 0.040 |
Why?
|
Follicular Phase | 1 | 2000 | 143 | 0.040 |
Why?
|
Brief Psychiatric Rating Scale | 1 | 2019 | 109 | 0.040 |
Why?
|
Serotonin Receptor Agonists | 1 | 2000 | 151 | 0.040 |
Why?
|
Hospital Mortality | 2 | 2023 | 5291 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2021 | 22124 | 0.040 |
Why?
|
Cognition | 3 | 2022 | 6987 | 0.040 |
Why?
|
Psychotropic Drugs | 1 | 2023 | 888 | 0.040 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2007 | 1491 | 0.040 |
Why?
|
Citalopram | 1 | 2020 | 402 | 0.040 |
Why?
|
Professional-Patient Relations | 1 | 2003 | 726 | 0.040 |
Why?
|
Receptors, Serotonin | 1 | 1997 | 208 | 0.030 |
Why?
|
Boston | 2 | 2012 | 9333 | 0.030 |
Why?
|
Hypnotics and Sedatives | 1 | 2023 | 1178 | 0.030 |
Why?
|
Electroconvulsive Therapy | 1 | 2020 | 500 | 0.030 |
Why?
|
Cardiac Surgical Procedures | 1 | 2010 | 3630 | 0.030 |
Why?
|
Consensus | 2 | 2017 | 3122 | 0.030 |
Why?
|
Incidence | 3 | 2017 | 21336 | 0.030 |
Why?
|
Length of Stay | 2 | 2020 | 6422 | 0.030 |
Why?
|
Angina, Unstable | 1 | 2019 | 888 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2023 | 2421 | 0.030 |
Why?
|
Mental Disorders | 2 | 2010 | 6839 | 0.030 |
Why?
|
Patient Participation | 1 | 2003 | 1443 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2193 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2023 | 1906 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2023 | 80575 | 0.030 |
Why?
|
tau Proteins | 1 | 2024 | 2095 | 0.030 |
Why?
|
Body Weight | 2 | 2000 | 4614 | 0.030 |
Why?
|
Confusion | 1 | 2014 | 278 | 0.030 |
Why?
|
Lung Diseases, Obstructive | 1 | 1993 | 308 | 0.020 |
Why?
|
Metabolomics | 1 | 2021 | 1656 | 0.020 |
Why?
|
Body Composition | 1 | 2000 | 2422 | 0.020 |
Why?
|
Risk Factors | 4 | 2022 | 74152 | 0.020 |
Why?
|
Outpatients | 1 | 2019 | 1596 | 0.020 |
Why?
|
Observation | 1 | 2012 | 310 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2024 | 3836 | 0.020 |
Why?
|
Eating | 1 | 1997 | 1537 | 0.020 |
Why?
|
Risk Assessment | 3 | 2017 | 23981 | 0.020 |
Why?
|
Prevalence | 3 | 2019 | 15719 | 0.020 |
Why?
|
Psychological Tests | 1 | 2012 | 640 | 0.020 |
Why?
|
United States | 4 | 2023 | 72317 | 0.020 |
Why?
|
Linear Models | 1 | 1999 | 5871 | 0.020 |
Why?
|
Mental Health | 1 | 2023 | 3248 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3806 | 0.020 |
Why?
|
Computational Biology | 1 | 2021 | 3512 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 29588 | 0.020 |
Why?
|
Parents | 1 | 2022 | 3564 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 1993 | 2217 | 0.020 |
Why?
|
Self Report | 1 | 2019 | 3724 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2010 | 999 | 0.020 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 1993 | 850 | 0.020 |
Why?
|
Adult | 10 | 2008 | 221122 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2014 | 2696 | 0.020 |
Why?
|
Cardiomyopathy, Dilated | 1 | 1993 | 829 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2012 | 968 | 0.020 |
Why?
|
Massachusetts | 1 | 2019 | 8837 | 0.020 |
Why?
|
Ultrasonography | 1 | 1999 | 5970 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13251 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 1997 | 10764 | 0.020 |
Why?
|
Comorbidity | 1 | 2019 | 10498 | 0.010 |
Why?
|
Placebos | 2 | 2000 | 1667 | 0.010 |
Why?
|
Sex Factors | 1 | 2017 | 10551 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8635 | 0.010 |
Why?
|
Proteomics | 1 | 2016 | 3843 | 0.010 |
Why?
|
Alcoholism | 1 | 1993 | 1973 | 0.010 |
Why?
|
Qualitative Research | 1 | 2012 | 3025 | 0.010 |
Why?
|
Patient Care Team | 1 | 1993 | 2523 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 2010 | 2189 | 0.010 |
Why?
|
Neuronal Plasticity | 1 | 2010 | 1435 | 0.010 |
Why?
|
Quality of Life | 1 | 2003 | 13355 | 0.010 |
Why?
|
Age Factors | 1 | 2017 | 18401 | 0.010 |
Why?
|
Disease Progression | 1 | 2017 | 13500 | 0.010 |
Why?
|
Electrocardiography | 1 | 1993 | 6382 | 0.010 |
Why?
|
Diet | 1 | 1997 | 8074 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39108 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 1997 | 306 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2014 | 26108 | 0.010 |
Why?
|
Databases, Factual | 1 | 2012 | 7954 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 12972 | 0.010 |
Why?
|
Research Design | 1 | 2012 | 6178 | 0.010 |
Why?
|
Models, Statistical | 1 | 2010 | 5078 | 0.010 |
Why?
|
Hormones | 1 | 2000 | 867 | 0.010 |
Why?
|
Hemoglobins | 1 | 2001 | 1524 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 64645 | 0.010 |
Why?
|
Single-Blind Method | 1 | 1997 | 1571 | 0.010 |
Why?
|
Middle Aged | 3 | 2010 | 220774 | 0.010 |
Why?
|
Reference Values | 1 | 2000 | 4921 | 0.010 |
Why?
|
Brain | 1 | 1997 | 27103 | 0.010 |
Why?
|
Body Mass Index | 1 | 2007 | 12949 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 1995 | 2075 | 0.000 |
Why?
|
Nutritional Status | 1 | 1997 | 1613 | 0.000 |
Why?
|
Health Status | 1 | 2001 | 4075 | 0.000 |
Why?
|
Pilot Projects | 1 | 1995 | 8632 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1995 | 12329 | 0.000 |
Why?
|
Adolescent | 1 | 1995 | 88305 | 0.000 |
Why?
|